BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24160291)

  • 1. The impact of the genome-wide supported variant in the cyclin M2 gene on gray matter morphology in schizophrenia.
    Ohi K; Hashimoto R; Yamamori H; Yasuda Y; Fujimoto M; Umeda-Yano S; Fukunaga M; Watanabe Y; Iwase M; Kazui H; Takeda M
    Behav Brain Funct; 2013 Oct; 9():40. PubMed ID: 24160291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a novel schizophrenia risk variant rs7914558 at CNNM2 on brain structure and attributional style.
    Rose EJ; Hargreaves A; Morris D; Fahey C; Tropea D; Cummings E; Caltagirone C; Bossù P; Chiapponi C; Piras F; Spalletta G; Gill M; Corvin A; Donohoe G
    Br J Psychiatry; 2014 Feb; 204(2):115-21. PubMed ID: 24311551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-stage replication of previous genome-wide association studies of AS3MT-CNNM2-NT5C2 gene cluster region in a large schizophrenia case-control sample from Han Chinese population.
    Guan F; Zhang T; Li L; Fu D; Lin H; Chen G; Chen T
    Schizophr Res; 2016 Oct; 176(2-3):125-130. PubMed ID: 27401531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness.
    Torres US; Duran FL; Schaufelberger MS; Crippa JA; Louzã MR; Sallet PC; Kanegusuku CY; Elkis H; Gattaz WF; Bassitt DP; Zuardi AW; Hallak JE; Leite CC; Castro CC; Santos AC; Murray RM; Busatto GF
    Neuroimage Clin; 2016; 12():1-15. PubMed ID: 27354958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the genome wide supported NRGN gene on anterior cingulate morphology in schizophrenia.
    Ohi K; Hashimoto R; Yasuda Y; Nemoto K; Ohnishi T; Fukumoto M; Yamamori H; Umeda-Yano S; Okada T; Iwase M; Kazui H; Takeda M
    PLoS One; 2012; 7(1):e29780. PubMed ID: 22253779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ZNF804a on brain structure volumes and symptom severity in individuals with schizophrenia.
    Wassink TH; Epping EA; Rudd D; Axelsen M; Ziebell S; Fleming FW; Monson E; Ho BC; Andreasen NC
    Arch Gen Psychiatry; 2012 Sep; 69(9):885-92. PubMed ID: 22945618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide significant schizophrenia risk variation on chromosome 10q24 is associated with altered cis-regulation of BORCS7, AS3MT, and NT5C2 in the human brain.
    Duarte RRR; Troakes C; Nolan M; Srivastava DP; Murray RM; Bray NJ
    Am J Med Genet B Neuropsychiatr Genet; 2016 Sep; 171(6):806-14. PubMed ID: 27004590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of genome wide supported microRNA-137 (MIR137) risk variants on frontal and striatal white matter integrity, neurocognitive functioning, and negative symptoms in schizophrenia.
    Kuswanto CN; Sum MY; Qiu A; Sitoh YY; Liu J; Sim K
    Am J Med Genet B Neuropsychiatr Genet; 2015 Jul; 168B(5):317-26. PubMed ID: 25921703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide supported psychosis risk variant in ZNF804A gene and impact on cortico-limbic WM integrity in schizophrenia.
    Kuswanto CN; Woon PS; Zheng XB; Qiu A; Sitoh YY; Chan YH; Liu J; Williams H; Ong WY; Sim K
    Am J Med Genet B Neuropsychiatr Genet; 2012 Apr; 159B(3):255-62. PubMed ID: 22328493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia.
    Zinkstok J; Schmitz N; van Amelsvoort T; Moeton M; Baas F; Linszen D
    Genes Brain Behav; 2008 Feb; 7(1):61-9. PubMed ID: 17504246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of genome-wide supported schizophrenia risk variants in the neurogranin gene on brain structure and function.
    Walton E; Geisler D; Hass J; Liu J; Turner J; Yendiki A; Smolka MN; Ho BC; Manoach DS; Gollub RL; Roessner V; Calhoun VD; Ehrlich S
    PLoS One; 2013; 8(10):e76815. PubMed ID: 24098564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between polymorphisms of the CXCL12 and CNNM2 gene and hypertension risk: A case-control study.
    Liu X; Chen L; Zhang Y; Wu X; Zhao Y; Wu X; Chen W; Wu C; Chen Y
    Gene; 2018 Oct; 675():185-190. PubMed ID: 30180964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association analysis of microRNA137 and its target complex 1 with schizophrenia in Han Chinese.
    Lu W; Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
    Sci Rep; 2017 Nov; 7(1):15084. PubMed ID: 29118371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voxel-Based Morphometry in Individuals at Genetic High Risk for Schizophrenia and Patients with Schizophrenia during Their First Episode of Psychosis.
    Chang M; Womer FY; Bai C; Zhou Q; Wei S; Jiang X; Geng H; Zhou Y; Tang Y; Wang F
    PLoS One; 2016; 11(10):e0163749. PubMed ID: 27723806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voxel-based morphometry versus region of interest: a comparison of two methods for analyzing gray matter differences in schizophrenia.
    Giuliani NR; Calhoun VD; Pearlson GD; Francis A; Buchanan RW
    Schizophr Res; 2005 May; 74(2-3):135-47. PubMed ID: 15721994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the BDNF Val66Met polymorphism on regional gray matter volumes and cognitive function in the Chinese population.
    Liu ME; Huang CC; Chen MH; Yang AC; Tu PC; Yeh HL; Hong CJ; Chen JF; Hwang JP; Lin CP; Tsai SJ
    Neuromolecular Med; 2014 Mar; 16(1):127-36. PubMed ID: 24366608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association study of the G72 gene with schizophrenia in a Japanese population: a multicenter study.
    Ohi K; Hashimoto R; Yasuda Y; Yoshida T; Takahashi H; Iike N; Fukumoto M; Takamura H; Iwase M; Kamino K; Ishii R; Kazui H; Sekiyama R; Kitamura Y; Azechi M; Ikezawa K; Kurimoto R; Kamagata E; Tanimukai H; Tagami S; Morihara T; Ogasawara M; Okochi M; Tokunaga H; Numata S; Ikeda M; Ohnuma T; Ueno S; Fukunaga T; Tanaka T; Kudo T; Arai H; Ohmori T; Iwata N; Ozaki N; Takeda M
    Schizophr Res; 2009 Apr; 109(1-3):80-5. PubMed ID: 19237267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the neurogranin schizophrenia risk variant rs12807809 on brain structure and function.
    Rose EJ; Morris DW; Fahey C; Robertson IH; Greene C; O'Doherty J; Newell FN; Garavan H; McGrath J; Bokde A; Tropea D; Gill M; Corvin AP; Donohoe G
    Twin Res Hum Genet; 2012 Jun; 15(3):296-303. PubMed ID: 22856365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the VAV3 as candidate gene for schizophrenia: evidences from voxel-based morphometry and mutation screening.
    Aleksic B; Kushima I; Hashimoto R; Ohi K; Ikeda M; Yoshimi A; Nakamura Y; Ito Y; Okochi T; Fukuo Y; Yasuda Y; Fukumoto M; Yamamori H; Ujike H; Suzuki M; Inada T; Takeda M; Kaibuchi K; Iwata N; Ozaki N
    Schizophr Bull; 2013 May; 39(3):720-8. PubMed ID: 22416266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.